Back to Search Results
Vincent Pompili
Schedule an appointment (614) 293-7677
Insurances We Accept
Vincent J. Pompili, MD, FACC, is section director of Interventional Cardiovascular Medicine, director of cardiovascular cell-based therapies, medical director of the cardiac cath labs and professor of internal medicine at The Ohio State University Medical Center.

Dr. Pompili earned his medical degree at Case Western Reserve University School of Medicine in Cleveland, Ohio, and completed his residency in internal medicine at The John Hopkins University in Baltimore, Md. Dr. Pompili also completed a fellowship in cardiovascular medicine at the University of Michigan in Ann Arbor, Mich., and a fellowship in interventional cardiology at Mayo Clinic in Rochester, Minn.

Dr. Pompili has published many abstracts, articles and peer-reviewed manuscripts in prestigious peer-reviewed journals including Science and Circulation. Over the past eight years, Dr. Pompili has pioneered novel approaches of research in the areas of translational stem cell therapies for patients with severe cardiovascular and peripheral vascular disease.

He has successfully completed the third U.S. FDA-approved NIH-sponsored trial in cardiovascular stem cell therapy and currently is actively investigating cell therapy options in the setting of phase I and phase II clinical trials.

Dr. Pompili’s clinical interests include complex interventional cardiology and management of acute coronary syndromes, and his research focuses on translational cardiovascular regenerative medicine and stem cell therapeutics. Dr. Pompili was named one of America’s Best Doctors in 2009.

Highlights

  • Rated in the top 10 percent of physicians in the nation for patient satisfaction, 2014, 2016

Medical Degree

  • M.D.
    Case Western Reserve University School of Medicine
    5/16/1988

Residency

  • Internal Medicine
    Johns Hopkins Hospital
    7/1/1989 - 6/30/1991

Specialties and conditions I treat

  • Interventional Cardiology
  • Cardiac Catheterization
  • Percutaneous Coronary Intervention
  • Acute Coronary Syndrome
  • Angioplasty
  • Cardiovascular Diseases
  • Coronary Care Units
  • Angioplasty, Balloon
  • Angioplasty, Balloon, Coronary
  • Coronary Artery Disease
  • Coronary Disease
  • Heart Valve Diseases
  • Hypercholesterolemia
  • Hypertension

My videos

Locations where I practice

Please note: Not all physicians schedule patients at each listed location. Please call the “Schedule an appointment” number shown above for scheduling assistance.

More about my work

My background

Fellowships

  • Interventional Cardiology
    Mayo Clinic
    6/25/1994 - 6/30/1995
  • Cardiovascular Medicine
    University of Michigan Hospitals
    7/1/1991 - 6/30/1994

Board Certifications

American Board of Internal Medicine
9/25/1991

American Board of Internal Medicine (Subspecialty: Cardiovascular)
11/10/1995

American Board of Internal Medicine (Subspecialty: Interventional Cardiology)
11/3/2004

My Department

Internal Medicine

My Division

Cardiovascular Medicine

Industry Relationships

At The Ohio State University Wexner Medical Center, we support a faculty member’s research and consulting in collaboration with medical device, research and/or drug companies because a faculty member’s expertise can guide important advancements in the practice of medicine and improve patient care. In order to provide effective management of these relationships, the University requires annual disclosures from all faculty members with external interests related to their University responsibilities.

As of 03/25/2016, Dr. Pompili has reported financial relationships with the medical device, research and/or drug companies listed below. If you have questions about the relationships listed below, please ask the faculty member. If you have questions about how these relationships are monitored by The Ohio State University Wexner Medical Center, please contact our Compliance Office at 614-293-7802.

  • Arteriocyte Medical Systems, Inc.
  • Arteriocyte, Inc.
  • Boston Scientific
  • Cardinal Health, Inc.